Vaccination is one of the most cost-effective ways to prevent infection. Influenza vaccines propagated in cultured cells are approved for use in humans, but their yields are often suboptimal. Here, we screened A/Puerto Rico/8/34 (PR8) virus mutant libraries to develop vaccine backbones (defined here as the six viral RNA segments not encoding haemagglutinin and neuraminidase) that support high yield in cell culture.
Original Source [2]
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/development-high-yield-influenza-virus-vaccine-viruses
[2] http://www.nature.com/articles/ncomms9148
[3] http://admin.indiaenvironmentportal.org.in/category/author/jihui-ping
[4] http://admin.indiaenvironmentportal.org.in/category/author/tiago-js-lopes
[5] http://admin.indiaenvironmentportal.org.in/category/author/chairul-nidom-et-al
[6] http://admin.indiaenvironmentportal.org.in/category/journal/nature-communications
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/influenza
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/viral-diseases
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/vaccination